Screener
Organogenesis Holdings Inc. ORGO Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:SecuredLongTermDebt.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed November 12, 2024.
- Filed
- Nov 12, 2024
- Fiscal quarter
- Q3 FY2024
- Calendar quarter
- Q3 2024
- Accession
- 0000950170-24-125431
| Line item | September 30, 2024 | December 31, 2023 |
|---|---|---|
| Accounts payable | 23,971 | 30,724 |
| Accrued expenses and other current liabilities | 36,101 | 30,074 |
| Total current liabilities | 77,281 | 80,509 |
| Term loan, net of current portion | 56,153 | 60,745 |
| Finance lease obligations, net of current portion | 1,019 | 1,888 |
| Operating lease obligations, net of current portion - related party | 9,217 | 11,954 |
| Operating lease obligations, net of current portion | 22,785 | 25,053 |
| Other liabilities | 1,294 | 1,213 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is Organogenesis Holdings Inc.'s long-term debt?
- Organogenesis Holdings Inc. (ORGO) reported long-term debt of $56.15M in Q3 2024.
- How has Organogenesis Holdings Inc.'s long-term debt changed year-over-year?
- Organogenesis Holdings Inc.'s long-term debt decreased by 9.6% year-over-year, from $62.12M to $56.15M.
- What is the long-term trend for Organogenesis Holdings Inc.'s long-term debt?
- Over 3 years (2020 to 2023), Organogenesis Holdings Inc.'s long-term debt has grown at a 12.2% compound annual growth rate (CAGR), from $43.04M to $60.75M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Organogenesis Holdings Inc.'s long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude